Simon Johns

A significant increase in Scientific Advisor roles has been observed in Q1 of this year. If this trend continues, there will be a 118% rise compared to last year. 📈 Discover more data-driven insights in the latest report by Cpl Life Sciences and Vacancysoft: https://zurl.co/3AhQ #lifesciences #datainsights

2

💻Dive into the latest advancements in SMRS & Medicines Optimisation in our upcoming webinar. Gain insights to elevate patient care and optimize treatment outcomes. 27th June , 9.30am-12.30pm , Scotland and other regions (online) Some Topics discussed include: -Respiratory & Sustainability in Qof and DES -Overview of common respiratory conditions in primary care -Importance of optimising medication in respiratory care -Benefits of SMRs in respiratory care For a full agenda and to book click below- https://lnkd.in/gHn8KnBw #MORPh #clinicalservices #pharmacists #professionals #webinar #FREEeducation

1

Did you know that 9% of all global ongoing #ATMP clinical trials have representation in the UK? ➡️https://ow.ly/GsRC50TTluX Learn more about the current state of the UK's #AdvancedTherapies sector in the Cell and Gene Therapy Catapult Annual Review 2024 Learn more ☝ #️GeneTherapy #CellTherapy #Innovation #Collaboration #CGTCatapult

15

Join Matthew Hewitt's presentation, “Fast technology coupled with deliberate regulatory: How can the field adapt new guidance to meet therapeutic demand?” CAR-TCR Summit Series As the number of CGT market approvals accelerates, Matt will discuss challenges in manufacturing and address how working collaboratively with partners and regulators aids in tackling the pain points of therapeutic development and clinical trial design. Don't miss this insightful session on regulatory guidance. https://okt.to/KTZMwk #cartcr #cgtdevelopment #celltherapy

17

Check out AscellaHealth Europe strategic Market Access Guide for Biotech/Pharma Organisations, providing insights on how to bring your specialty and rare disease products to market successfully. This step-by-step guide covers how to develop an effective master plan for all of the elements that drive commercial success of your product. Download it here: https://lnkd.in/eJPc6uBm #raredisease #drugdevelopment #clinicaltrials #marketaccess #pharmaceutical #AscellaHealth

2

Large and midsize pharma are reassessing their outsourcing requirements and customising new models to navigate the complex development landscape. Tony Southers, ICON’s Head of Strategic Solutions, discusses the industry’s move towards blended sourcing models to capitalise on the advantages of both FSP and FSO. Learn how to realise the benefits of blended models in our article: https://ow.ly/X6Ca50THHsO

91

10 Comments

Large and midsize pharma are reassessing their outsourcing requirements and customising new models to navigate the complex development landscape. Tony Southers, ICON’s Head of Strategic Solutions, discusses the industry’s move towards blended sourcing models to capitalise on the advantages of both FSP and FSO. Learn how to realise the benefits of blended models in our article: https://ow.ly/X6Ca50THHsO

49

8 Comments

Join us for our Upcoming Webinar: Enhancing Decentralised Clinical Trials: The Power of Direct to Patient Distribution. Are you ready to revolutionise your clinical trials? Discover cutting-edge strategies and best practices for direct-to-patient distribution that can enhance efficiency, patient engagement, and trial outcomes with Almac Expert David Ergott. Register today: https://hubs.li/Q02PsBwY0

27

📊 Webinar Alert! Real-world evidence (RWE) is transforming clinical development and healthcare decision-making. Join us on Tuesday 19th November, 2024, at 4pm GMT/ 11am EST/ 8am PST, for a webinar exploring how to unlock the full potential of RWE to enhance drug development. Our expert panel will explore key topics, including data sources, how RWE complements clinical trial data and present a case study where RWE has been effectively used. Don’t miss this chance to learn how RWE can drive innovation in clinical development and improve patient outcomes! 👉 Register here: https://lnkd.in/eZUz8UcQ #RealWorldEvidence #RWE #ClinicalTrials #Pharma #Healthcare

31

6 Comments

Wondering how to accelerate #NGS data analysis in a GMP-compliant environment? Join our webinar where Head of Scientific Consulting Devon Ryan will showcase how Genedata solutions enable next-generation automation and tracking of NGS workflows: https://buff.ly/3OBLHQQ #DigitalizingBiopharma #Playbooks #Automation #GenedataSelector

26

🔎 Five trends are shaping the future of the life sciences industry. Employers must improve what they offer to candidates or risk being left behind in the race for talent. Everything from gene editing to decentralised clinical trials are sucking in expertise and there may not be enough people with relevant skills to fill all the roles that are likely to be offered in the coming months. Read more in our article 👉 https://lnkd.in/e2wGTG9m #lifesciences #AI #trends 

6

1 Comment

Medical affairs leaders — who’s driving the technology in your organization? Too often, medical affairs teams find themselves inheriting complex, overbearing software or cobbled-together solutions that don’t meet their needs. But what if Medical Affairs became the drivers of their tech solutions instead? 📽️ Catch the full webinar, "Empowering Medical Affairs: Streamlining Operations with Technology," for more insights and solutions: https://lnkd.in/exdWDwn4

7

We’re excited to introduce Arkivum’s latest eBook, A Complete Guide to Data Standards for Clinical Trial Data. This essential resource consolidates key data standards designed to help organisations navigate compliance with regulatory frameworks from the FDA, EMA, and MHRA. In our eBook, we explore the very latest guidelines and standards, including ICH E6 (R3) and Version 4 of the TMF Reference Model. Access here: https://bit.ly/41rR6BH

3

Europe presents a significant opportunity for international biotech’s developing and commercialising rare and orphan medicines. With the EMA’s increasing focus on Real-World Data in its regulatory processes, there are several ways in which applying it can help speed up access to the European market. Download this exclusive guide to discover how Real-World Data can improve your chance of success in this complex market. https://lnkd.in/eaS6NKPf #raredisease #realworlddata #orphandrugs

14

🔍Explore Biopharma Group's new case study on Lyobeads for In-Vitro Diagnostics🔍 This case study highlights how Biopharma Group's team of dedicated scientists successfully optimised a lyophilised IVD kit whilst increasing batch acceptance rate and eliminating the cold chain. If you would like to discuss this case study in more detail or have a diagnostic project of your own that you require support with then please get in touch: https://bit.ly/3H9yivP #diagnostics #casestudy #lyobeadcasestudy #coldchain #IVDkit #IVDR #BiopharmaGroup

14

Like many today, we are celebrating #ClinicalTrialsDay so what better time to ask the question…. ❔ How can we collectively advance clinical research for more patients and overcome complexities in trial set up and delivery? PHARMExcel has been transforming the UK clinical trial landscape for 15 years providing bespoke CRO support for academic and commercial trials (IMP and medical device). During its journey we’ve had the privilege of building partnerships with NHS Trusts, Universities, Sponsors and Sites across the UK. These successful partnerships are underpinned by 4 important values: 1. Honesty and genuine collaboration 2. Quality and Excellence 3. Experience and Expertise 4. Responsiveness and Flexibility It’s these 4 values that drive successful outcomes for our trials across a broad range of therapeutic areas including complex ATMP trials. To learn how these key values translate into trial deliverables you can read our blog here 👉 https://lnkd.in/etAeUq3E On #ClinicalTrialsDay we want to thank all our partners, colleagues and most importantly the patients for working with us to help advance research and improve healthcare and well-being for all. If you need help in progressing your clinical trials please get in touch [email protected] #ClinicalTrialsDay #ClinicalResearch #ClinicalTrials #QualityInResearch

4

The The Association of the British Pharmaceutical Industry (ABPI) has published its 2024 report on industry clinical trials - a review of the UK's performance and recommendations for the future. We welcome the ABPI’s annual report on the road to recovery for UK industry clinical trials. It is encouraging to see the improvement in the UK’s rankings for phase 2 and phase 3 trials and UKRD wishes to acknowledge, in particular, the hard work of the UK clinical research workforce and NHS organisations that host industry trials. We welcome the clarity in the report around the areas requiring continued focus; the outcomes of our recent UKRD survey of clinical trials set up and delivery (https://lnkd.in/ePzHvSub) also emphasised the need for all system partners to work together to continue to drive systems improvements and we look forward to working together across the industry to drive positive change.

6